McSharry Heather Ann
SEC Form 4 insider trading activity
McSharry Heather Ann has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Sep 2, 2026.
On the most recent filing, McSharry Heather Ann is listed as Director at Jazz Pharmaceuticals plc. Inside the rolling window, McSharry Heather Ann reported no open-market purchases and 2 open-market sales totaling $1.1M in JAZZ. The largest disclosed transaction in the window is a sale of 3,415 JAZZ shares on Nov 20, 2025, worth $607K.
Companies traded
Other insiders at JAZZ
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.1M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has McSharry Heather Ann made?
McSharry Heather Ann has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does McSharry Heather Ann trade?
McSharry Heather Ann has filed SEC Form 4 disclosures for 1 company, including JAZZ.
When was McSharry Heather Ann's most recent SEC Form 4 filing?
McSharry Heather Ann's most recent SEC Form 4 filing on Tracefour is dated Sep 2, 2026.
What is McSharry Heather Ann's total buy and sell value in the current window?
Inside the rolling retention window, McSharry Heather Ann bought $0 and sold $1.1M based on SEC Form 4 filings.
What was McSharry Heather Ann's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,415 JAZZ shares on 2025-11-20, worth $607K, per SEC Form 4 filings.